Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Nathaniel Luke Walker > Profile

Nathaniel Luke Walker

Affiliations

  • Director at Zentalis Pharmaceuticals Inc. (ZNTL), 2025-06-18
  • Director at Context Therapeutics Inc. (CNTX), 2025-06-12
  • Chief Medical Officer at Harpoon Therapeutics Inc. (HARP), 2024-03-11
  • Svp, Clinical Development at Cascadian Therapeutics Inc. (CASC), 2018-03-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ZNTL $1.76 14,200 $24,966.44 86,681 2025-01-31 Filing